He has served as an EVP for a Fortune 500 company and as an officer of 3 medical device start-ups, most recently as CEO of Grove Instruments, Inc. The concentration of his work has been in breakthrough noninvasive medical devices. More than half a dozen unique medical devices have been brought to market under his leadership. Two of his start-up companies had successful M&A exists, and the third and a [fourth] spinout remain in business today. Art's focus is identifying important unmet needs, seeking unique technological and clinically meaningful solutions that enable feasible business models and value creation opportunities.